Journal article icon

Journal article

Creation of a novel class of potent and selective MutT Homologue 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design

Abstract:

Recent literature has both suggested and questioned MTH1 as a novel cancer target. BAY-707 was just published as a target validation small molecule probe for assessing the effects of pharmacological inhibition of MTH1 on tumor cell survival, both in vitro and in vivo. (1) In this report, we describe the medicinal chemistry program creating BAY-707, where fragment-based methods were used to develop a series of highly potent and selective MTH1 inhibitors. Using structure-based drug design and r...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1021/acs.jmedchem.7b01884

Authors


More by this author
Role:
Author
ORCID:
0000-0002-4087-9721
Expand authors...
Publisher:
American Chemical Society Publisher's website
Journal:
Journal of Medicinal Chemistry Journal website
Volume:
61
Issue:
6
Pages:
2533–2551
Publication date:
2018-02-27
DOI:
EISSN:
1520-4804
ISSN:
0022-2623
Pubs id:
pubs:828329
URN:
uri:669bb577-bb66-4555-938c-49a866081107
UUID:
uuid:669bb577-bb66-4555-938c-49a866081107
Local pid:
pubs:828329
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP